Publicacións (269) Publicacións nas que participase algún/ha investigador/a

filter_list

2025

  1. Belimumab patient profile in Spain: evolution during the last decade and future directions

    Expert Opinion on Biological Therapy, Vol. 25, Núm. 4, pp. 425-435

  2. Cerebrovascular accidents in giant cell arteritis: prevalence and predictive factors from the ARTESER registry

    Rheumatology, Vol. 64, Núm. 6, pp. 3733-3738

  3. Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project

    Arthritis and Rheumatology, Vol. 77, Núm. 4, pp. 477-489

  4. Clinical significance of anti-Ro and Anti-La antibodies: The role of isolated anti-La

    Lupus

  5. Clinical significance of anti-Ro and Anti-La antibodies: The role of isolated anti-La

    Lupus, Vol. 34, Núm. 6, pp. 571-578

  6. DNA methylome biomarkers of rheumatoid arthritis-associated interstitial lung disease reflecting lung fibrosis pathways, an exploratory case–control study

    Scientific Reports, Vol. 15, Núm. 1

  7. Disease activity in patients with idiopathic inflammatory myopathy according to time since diagnosis and positivity to antisynthetase autoantibodies: data from the Myo-Spain registry

    Arthritis research & therapy, Vol. 27, Núm. 1, pp. 5

  8. ERN ReCONNET–SLICC–SLEuro expert consensus on the therapeutic management of rare systemic lupus erythematosus manifestations

    The Lancet Rheumatology, Vol. 7, Núm. 7, pp. e505-e518

  9. Long-term changes in Sjögren's disease: a 9-year prospective follow-up study from the SJOGRENSER Registry

    Rheumatology international, Vol. 45, Núm. 7, pp. 156

  10. Mortality in Patients With Sjögren Disease: A Prospective Cohort Study Identifying Key Predictors

    Journal of Rheumatology, Vol. 52, Núm. 3, pp. 257-262

  11. Mortality in patients with giant cell arteritis in Spain: results from the ARTESER registry

    Arthritis Research and Therapy, Vol. 27, Núm. 1

  12. Real-world evidence of the antifibrotic nintedanib in rheumatoid arthritis-interstitial lung disease. National multicenter study of 74 patients

    Seminars in Arthritis and Rheumatism, Vol. 72

  13. Thorough assessment of the effectiveness of belimumab in a large Spanish multicenter cohort of systemic lupus erythematosus patients

    Rheumatology, Vol. 64, Núm. 1, pp. 276-282

  14. VEXAS syndrome through a rheumatologist’s lens: insights from a Spanish national cohort

    Rheumatology, Vol. 64, Núm. 6, pp. 3747-3755

  15. Visual manifestations in giant cell arteritis: Identification of risk factors from the ARTESER Registry

    Rheumatology, Vol. 64, Núm. 2, pp. 697-703

2024

  1. 18F-FDG-PET/CT Scan for Detection of Large Vessel Involvement in Giant Cell Arteritis: Arteser Spanish Registry

    Journal of Clinical Medicine, Vol. 13, Núm. 20

  2. Abatacept in usual and in non-specific interstitial pneumonia associated with rheumatoid arthritis

    European Journal of Internal Medicine, Vol. 119, pp. 118-124

  3. An update of murine models and their methodologies in immune-mediated joint damage and pain research

    International Immunopharmacology, Vol. 128

  4. Assessment of the Effective Sensitivity of SARS-CoV-2 Sample Pooling Based on a Large-Scale Screening Experience: Retrospective Analysis

    JMIR public health and surveillance, Vol. 10, pp. e54503

  5. Can the dose of belimumab be reduced in patients with systemic lupus erythematosus?

    Rheumatology